` 2500 (Venus Medtech Hangzhou Inc) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

2500
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, Venus Medtech Hangzhou Inc has underperformed Hang Seng (Hong Kong), delivering a return of -58% compared to the Hang Seng (Hong Kong)'s +7% growth.

Stocks Performance
2500 vs Hang Seng (Hong Kong)

Loading
2500
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
2500 vs Hang Seng (Hong Kong)

Performance Gap Between 2500 and HSI
HIDDEN
Show

Performance By Year
2500 vs Hang Seng (Hong Kong)

Loading
2500
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Venus Medtech Hangzhou Inc vs Peers

Hang Seng (Hong Kong)
2500
LEG
PMT
DFS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Venus Medtech Hangzhou Inc
Glance View

Market Cap
1B HKD
Industry
Health Care

Venus Medtech (Hangzhou), Inc. provides transcatheter heart valve medical device. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2019-12-10. The firm's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and TriGUARD3 Cerebral Embolic Protection Device.

Venus Medtech Hangzhou Inc Intrinsic Value
HIDDEN
Show
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett